ArticlePloS one2025
The association of race with time to severe liver disease diagnoses.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEvidence suggests that there are racial differences in liver fibrosis progression for patients with chronic liver disease (CLD). We examined the association of Black race with the time to diagnosis of severe liver disease outcomes in primary care patients.
methodsWe captured electronic health record data from a primary care clinic between 2012-2021. Race, categorized as Black and non-Black, was the primary exposure. The outcome was the occurrence of a severe liver event identified by ICD-9/10 codes, defined as a composite of cirrhosis, complications of cirrhosis, hepatocellular carcinoma, and liver transplantation. Cox regression models evaluated the association of Black race with the time to severe liver outcomes while adjusting for potentially confounding covariates.
resultsThe cohort included 20,828 patients of whom 43% identified as Black and 14% had a known diagnosis of CLD during follow-up. Of all patients, 3% received a diagnosis code for a severe liver event. In an unadjusted Cox regression model, Black race was associated with an increased hazard of a severe liver event (HR 1.32; 95%CI 0.98-1.34), but after adjusting for known CLD, baseline fibrosis risk, demographic, and comorbidity variables, Black race was associated with a significantly lower hazard of a severe liver outcome (HR 0.68; 95%CI 0.57-0.81).
conclusionsAfter adjusting for potentially confounding covariates, Black race was associated with a longer time to a severe liver disease diagnosis. This finding raises the possibilities of delayed cirrhosis detection or differences in liver fibrosis progression by racial identifiers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.